Skip to main content
. Author manuscript; available in PMC: 2015 Aug 21.
Published in final edited form as: J Asthma. 2014 Mar 6;51(6):610–617. doi: 10.3109/02770903.2014.892966

Table 1.

Classification of asthma control modified from the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.

Measures for current impairment Well controlled Not well controlled Very poorly controlled
Symptoms ≤2 d/week >2 d/week Throughout the day
Nighttime awakenings ≤1×/month (aged 0–4 yrs)
≤1×/month (aged 5–11 yrs)
≤2×/month (aged ≥12 yrs)
>1×/month (aged 0–4 yrs)
≥2×/month (aged 5–11 yrs)
1–3×/week (aged ≥12 yrs)
>1×/week (aged 0–4 yrs)
≥2×/week (aged 5–11 yrs)
≥4×/week (aged ≥12 yrs)
Short-acting β2-agonists used
 for symptom control
≤2 d/week >2 d/week   Several times/day